BACKGROUND: Separate health-related quality of life (HRQL) instruments exist for asthma and rhinitis. The Rhinasthma questionnaire, originally developed in Italian, is a unique measure designed for use where both conditions coexist. OBJECTIVE: We sought to assess the performance and validity of a new adaptation of the Rhinasthma questionnaire for use in English-speaking populations. METHODS: We analyzed cross-sectional data from an ongoing study of adults with asthma and rhinitis (n = 450), asthma alone (n = 75), or rhinitis alone (n = 20). Subjects were administered an English translation of the original 30-item Rhinasthma questionnaire. Health status measures simultaneously assessed include the Short Form (SF)-12, EuroQol (EQ)-5D, and Marks Asthma Quality-of-Life. RESULTS: Variable cluster analysis of the original 30-item instrument identified 5 discrete item clusters corresponding to the following domains: nasal (5 items), eye (4 items), respiratory (5 items), activity restriction (9 items), and treatment burden (5 items). Two other items were removed because of poor item-cluster correlations. Subjects with concomitant asthma and rhinitis had greater HRQL impairment, as measured by the Rhinasthma, than subjects with either asthma or rhinitis alone. The Rhinasthma correlated significantly (P < .05) with the SF-12, EQ-5D, and Marks Asthma Quality-of-Life in the anticipated direction consistent with the underlying constructs. In multiple logistic regression, poorer Rhinasthma HRQL was associated with significantly (P < .05) increased odds of both asthma- and rhinitis-related disability even after taking into account physical health status as measured by the SF-12. CONCLUSION: The 28-item English adaptation of Rhinasthma performs well in assessing HRQL in patients with asthma, rhinitis, or both conditions combined.
BACKGROUND: Separate health-related quality of life (HRQL) instruments exist for asthma and rhinitis. The Rhinasthma questionnaire, originally developed in Italian, is a unique measure designed for use where both conditions coexist. OBJECTIVE: We sought to assess the performance and validity of a new adaptation of the Rhinasthma questionnaire for use in English-speaking populations. METHODS: We analyzed cross-sectional data from an ongoing study of adults with asthma and rhinitis (n = 450), asthma alone (n = 75), or rhinitis alone (n = 20). Subjects were administered an English translation of the original 30-item Rhinasthma questionnaire. Health status measures simultaneously assessed include the Short Form (SF)-12, EuroQol (EQ)-5D, and Marks Asthma Quality-of-Life. RESULTS: Variable cluster analysis of the original 30-item instrument identified 5 discrete item clusters corresponding to the following domains: nasal (5 items), eye (4 items), respiratory (5 items), activity restriction (9 items), and treatment burden (5 items). Two other items were removed because of poor item-cluster correlations. Subjects with concomitant asthma and rhinitis had greater HRQL impairment, as measured by the Rhinasthma, than subjects with either asthma or rhinitis alone. The Rhinasthma correlated significantly (P < .05) with the SF-12, EQ-5D, and Marks Asthma Quality-of-Life in the anticipated direction consistent with the underlying constructs. In multiple logistic regression, poorer Rhinasthma HRQL was associated with significantly (P < .05) increased odds of both asthma- and rhinitis-related disability even after taking into account physical health status as measured by the SF-12. CONCLUSION: The 28-item English adaptation of Rhinasthma performs well in assessing HRQL in patients with asthma, rhinitis, or both conditions combined.
Authors: Liisa K Airaksinen; Ritva A Luukkonen; Irmeli Lindström; Antti I Lauerma; Elina M Toskala Journal: J Occup Environ Med Date: 2009-11 Impact factor: 2.162
Authors: M Gaga; P Lambrou; N Papageorgiou; N G Koulouris; E Kosmas; S Fragakis; C Sofios; A Rasidakis; J Jordanoglou Journal: Clin Exp Allergy Date: 2000-05 Impact factor: 5.018
Authors: I Baiardini; M Pasquali; A Giardini; C Specchia; G Passalacqua; S Venturi; F Braido; S Bonini; G Majani; G W Canonica Journal: Allergy Date: 2003-04 Impact factor: 13.146
Authors: Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby Journal: JAMA Date: 2002-05-15 Impact factor: 56.272
Authors: Paul D Blanc; Patricia J Quinlan; Patricia P Katz; John R Balmes; Laura Trupin; Miriam G Cisternas; Larry Wymer; Stephen J Vesper Journal: Environ Res Date: 2013-02-16 Impact factor: 6.498
Authors: Laura Trupin; Patricia P Katz; John R Balmes; Hubert Chen; Edward H Yelin; Theodore Omachi; Paul D Blanc Journal: Am J Public Health Date: 2012-12-13 Impact factor: 9.308
Authors: John R Balmes; Miriam Cisternas; Patricia J Quinlan; Laura Trupin; Fred W Lurmann; Patricia P Katz; Paul D Blanc Journal: Environ Res Date: 2014-01-11 Impact factor: 6.498
Authors: Adem Sav; Michelle A King; Jennifer A Whitty; Elizabeth Kendall; Sara S McMillan; Fiona Kelly; Beth Hunter; Amanda J Wheeler Journal: Health Expect Date: 2013-01-31 Impact factor: 3.377
Authors: Mohammad Imanipour; Zahra Molazem; Mahnaz Rakhshan; Mohammad Javad Fallahi; Amir Mohammad Atashin Sadaf Journal: Invest Educ Enferm Date: 2022-03